WNT pathway inhibition sensitizes HAT1-high lung cancers to treatment with PD-1 inhibitors.

ABSTRACT:

SUBMITTER: Yang T 

PROVIDER: S-EPMC12648990 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature